What do we need to remove to let them heal?
For decades, the central nervous system's refusal to heal itself after injury has stood as one of medicine's most humbling boundaries. Researchers at Yale School of Medicine have now mapped 40 genes that actively enforce that boundary — biological brakes built into the body's own architecture. By silencing one of them, an immune regulator called interleukin-22, they coaxed damaged optic nerves in glaucoma-afflicted mice to regrow, suggesting that recovery may depend less on what we add to the nervous system than on what we learn to remove.
- Stroke, spinal cord injury, and traumatic brain injury leave millions with permanent deficits precisely because central nervous system cells, unlike peripheral nerves, cannot repair themselves — a limitation that has resisted medical intervention for generations.
- Yale researchers screened 400 candidate genes in mice and found that 40 of them are not passive bystanders but active suppressors, working against the nervous system's own potential for repair.
- Using RNA silencing and precision gene editing, the team deleted individual genes and measured real consequences in living animals — a methodological leap beyond what earlier, smaller studies could achieve.
- Removing the interleukin-22 gene triggered a cascade of changes in neuronal repair pathways, producing dramatic axon regrowth in the damaged optic nerves of glaucoma model mice.
- The findings reframe the central therapeutic question: rather than searching only for agents that stimulate nerve growth, scientists may now pursue treatments that lift the body's own molecular suppression of it.
The brain and spinal cord carry a stubborn biological limitation: when their nerve cells are damaged by stroke, injury, or disease, they do not repair themselves. A peripheral nerve in an arm or leg can mend after trauma. The central nervous system cannot. Neuroscientists have long suspected that something in the body was actively preventing regeneration, not merely failing to enable it.
A team at Yale School of Medicine set out to find those biological brakes. Screening 400 candidate genes in mice, they identified 40 that actively suppress the regrowth of axons — the threadlike extensions nerve cells use to communicate. Published in Cell Reports in March 2021, the work dramatically expands the field's map of what holds regeneration back. Earlier research had identified only a handful of such genes; newer tools for RNA silencing and precise gene editing allowed a far broader search.
One discovery stood apart. Deleting the gene encoding interleukin-22, an immune system regulator, reshaped the expression of many other genes involved in neuronal repair — and axons in the optic nerves of glaucoma-model mice regrew significantly. Senior author Stephen Strittmatter described it as a threshold moment, calling it a new chapter in regeneration research.
The implications extend well beyond glaucoma. If modifying these 40 genes can promote repair in the optic nerve, the same logic may apply to stroke, spinal cord injury, and traumatic brain injury — conditions that currently leave patients with permanent neurological deficits. Future work will test whether these interventions can restore function after such injuries.
What the Yale findings ultimately offer is a reframing of the question itself. The field has long asked what must be added to make nerves grow. These results suggest an equally important question: what must be removed to let them?
The brain and spinal cord have a stubborn limitation: when their nerve cells are damaged by stroke, injury, or disease, they simply do not repair themselves. A peripheral nerve in your arm or leg can mend after trauma. The central nervous system cannot. This asymmetry has frustrated neuroscientists for decades, who have long suspected that something in the body's own biology was actively preventing this regeneration rather than merely failing to enable it.
Researchers at Yale School of Medicine decided to hunt for those biological brakes. In a systematic screen of 400 candidate genes in mice, they identified 40 that actively suppress the regrowth of axons—the threadlike extensions that allow nerve cells to communicate with one another. The work, published in Cell Reports on March 2, 2021, represents a significant expansion of the field's understanding of what holds regeneration back.
The team's approach relied on newer molecular tools: RNA silencing techniques and gene editing technologies precise enough to remove individual genes and measure their functional consequences. Where earlier researchers had identified only a handful of regeneration-blocking genes, these advances allowed a much broader search. Of the 400 genes the Yale team had previously flagged as candidates in laboratory cultures of brain neurons, one in ten proved to have a direct effect on axon regeneration in living mice.
One particular finding stood out. When the researchers deleted a gene encoding interleukin-22, an immune system regulator, they saw a dramatic shift. The absence of this protein altered how many other genes involved in neuronal repair were expressed throughout the nervous system, and the result was substantial: axons in the optic nerves of mice with glaucoma regrew significantly. Stephen Strittmatter, the Vincent Coates Professor of Neurology at Yale and the study's senior author, called the discovery a threshold moment. "This opens a new chapter in regeneration research," he said.
The practical implications are substantial. Stroke, spinal cord injury, and traumatic brain injury all involve damage to central nervous system axons. If blocking or modifying these 40 genes could promote repair in those contexts as it did in the glaucoma model, the therapeutic possibilities would be transformative. Strittmatter indicated that future work would test whether manipulating these genes could restore function after the kinds of injuries that currently leave patients with permanent neurological deficits.
What makes this work significant is not just the number of genes identified, but the shift in thinking it represents. For years, the question was: what do we need to add to make nerves grow? The Yale findings suggest a different question may be equally important: what do we need to remove to let them?
Notable Quotes
This opens a new chapter in regeneration research— Stephen Strittmatter, Yale School of Medicine
The Hearth Conversation Another angle on the story
Why can peripheral nerves heal but central nervous system nerves cannot? Is it just a matter of biology being different?
It's more deliberate than that. The body appears to have active mechanisms—genes that are switched on—that specifically prevent central nervous system axons from regrowing. It's not passive failure; it's active suppression.
That's counterintuitive. Why would the body actively prevent healing?
There are evolutionary reasons. The central nervous system is highly organized and precise. Uncontrolled regrowth could create wrong connections, scrambling signals. But that protection comes at a cost when real injury occurs.
So by removing these genes, you're essentially removing the brakes.
Exactly. The Yale team found 40 genes acting as brakes. When they removed one—the interleukin-22 gene—axons in damaged optic nerves started regrowing in mice with glaucoma.
Does removing one gene affect the whole system, or is it localized?
Removing that single gene altered how many other regeneration-related genes were expressed throughout the nervous system. It's not just one switch; it's more like removing one domino that causes others to fall in a regenerative direction.
What happens next?
The real test is whether this works for stroke, spinal cord injury, and traumatic brain injury in humans. The glaucoma model was proof of concept. Now researchers need to see if the same approach can restore function after the injuries that currently leave people permanently disabled.